Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in J Clin Invest Retrieve available abstracts of 29 articles: HTML format

Single Articles

January 2021
1. GUO J, Liu Y, Lv J, Zou B, et al
   BCL6 confers KRAS-mutant non-small-cell lung cancer resistance to BET inhibitors.
   J Clin Invest. 2021;131.
   PubMed     Abstract available
   
   
   October 2020
2. HUANG F, Huffman K, Wang Z, Wang X, et al
   Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small cell lung cancer.
   J Clin Invest. 2020 Oct 20. pii: 139929. doi: 10.1172/JCI139929.
   PubMed     Abstract available
   
   
   
3. WHITESIDE TL
   NK cells in the tumor microenvironment and thioredoxin activity.
   J Clin Invest. 2020;130:5115-5117.
   PubMed     Abstract available
   
   
   
4. YANG Y, Neo SY, Chen Z, Cui W, et al
   Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells.
   J Clin Invest. 2020;130:5508-5522.
   PubMed     Abstract available
   
   
   August 2020
5. COCHRANE CR, Vaghjiani V, Szczepny A, Jayasekara WSN, et al
   Trp53 and Rb1 regulate autophagy and ligand-dependent Hedgehog signaling.
   J Clin Invest. 2020;130:4006-4018.
   PubMed     Abstract available
   
   
   July 2020
6. YAN C, Richmond A
   Th9 and Th17 cells: the controversial twins in cancer immunity.
   J Clin Invest. 2020;130:3409-3411.
   PubMed     Abstract available
   
   
   June 2020
7. LIU J, Zhang C, Wu H, Sun XX, et al
   Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.
   J Clin Invest. 2020;130:3253-3269.
   PubMed     Abstract available
   
   
   April 2020
8. CONEJO-GARCIA JR, Rodriguez PC
   c-Maf: a bad influence in the education of macrophages.
   J Clin Invest. 2020;130:1629-1631.
   PubMed     Abstract available
   
   
   
9. HU K, Li K, Lv J, Feng J, et al
   Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma.
   J Clin Invest. 2020;130:1752-1766.
   PubMed     Abstract available
   
   
   
10. VALENCIA K, Erice O, Kostyrko K, Hausmann S, et al
    The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas.
    J Clin Invest. 2020;130:1879-1895.
    PubMed     Abstract available
    
    
    March 2020
11. SALAZAR Y, Zheng X, Brunn D, Raifer H, et al
    Microenvironmental Th9- and Th17- lymphocytes induce metastatic spreading in lung cancer.
    J Clin Invest. 2020 Mar 31. pii: 124037. doi: 10.1172/JCI124037.
    PubMed     Abstract available
    
    
    February 2020
12. LIN M, Luo H, Liang S, Chen J, et al
    Pembrolizumab plus allogeneic NK cells in advanced non-small cell lung cancer patients.
    J Clin Invest. 2020 Feb 6. pii: 132712. doi: 10.1172/JCI132712.
    PubMed     Abstract available
    
    
    
13. BOUSQUET MUR E, Bernardo S, Papon L, Mancini M, et al
    Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma.
    J Clin Invest. 2020;130:612-624.
    PubMed     Abstract available
    
    
    January 2020
14. LIU M, Tong Z, Ding C, Luo F, et al
    Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer.
    J Clin Invest. 2020 Jan 16. pii: 131335. doi: 10.1172/JCI131335.
    PubMed     Abstract available
    
    
    
15. SIEBEN CJ, Jeganathan KB, Nelson GG, Sturmlechner I, et al
    BubR1 allelic effects drive phenotypic heterogeneity in mosaic-variegated aneuploidy progeria syndrome.
    J Clin Invest. 2020;130:171-188.
    PubMed     Abstract available
    
    
    November 2019
16. SUZUKI M, Cao K, Kato S, Komizu Y, et al
    Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.
    J Clin Invest. 2019;129:5050.
    PubMed    
    
    
    July 2019
17. SUZUKI M, Cao K, Kato S, Komizu Y, et al
    Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.
    J Clin Invest. 2019;130.
    PubMed    
    
    
    April 2019
18. KELLISH P, Shabashvili D, Rahman MM, Nawab A, et al
    Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival.
    J Clin Invest. 2019;130.
    PubMed     Abstract available
    
    
    January 2019
19. ZHAO G, Gong L, Su D, Jin Y, et al
    Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin beta1.
    J Clin Invest. 2019 Jan 28. pii: 122779. doi: 10.1172/JCI122779.
    PubMed     Abstract available
    
    
    
20. CHEN M, Zhang J, Berger AH, Diolombi MS, et al
    Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis.
    J Clin Invest. 2019;129:215-222.
    PubMed     Abstract available
    
    
    December 2018
21. CHABANON RM, Muirhead G, Krastev DB, Adam J, et al
    PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.
    J Clin Invest. 2018 Dec 27. pii: 123319. doi: 10.1172/JCI123319.
    PubMed     Abstract available
    
    
    April 2018
22. GONG K, Guo G, E Gerber D, Gao B, et al
    TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer.
    J Clin Invest. 2018 Apr 3. pii: 96148. doi: 10.1172/JCI96148.
    PubMed     Abstract available
    
    
    February 2018
23. TOUAT M, Sourisseau T, Dorvault N, Chabanon RM, et al
    DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade.
    J Clin Invest. 2018 Feb 15. pii: 90277. doi: 10.1172/JCI90277.
    PubMed     Abstract available
    
    
    January 2018
24. CHOCKLEY PJ, Chen J, Chen G, Beer DG, et al
    Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer.
    J Clin Invest. 2018 Jan 11. pii: 97611. doi: 10.1172/JCI97611.
    PubMed     Abstract available
    
    
    October 2017
25. WEI Y, Kim TJ, Peng DH, Duan D, et al
    Fibroblast-specific inhibition of TGF-beta1 signaling attenuates lung and tumor fibrosis.
    J Clin Invest. 2017;127:3675-3688.
    PubMed     Abstract available
    
    
    August 2017
26. JESCHKE J, Bizet M, Desmedt C, Calonne E, et al
    DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.
    J Clin Invest. 2017;127:3090-3102.
    PubMed     Abstract available
    
    
    
27. WANG YT, Chen J, Chang CW, Jen J, et al
    Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment.
    J Clin Invest. 2017;127:2982-2997.
    PubMed     Abstract available
    
    
    
28. AYERS M, Lunceford J, Nebozhyn M, Murphy E, et al
    IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade.
    J Clin Invest. 2017;127:2930-2940.
    PubMed     Abstract available
    
    
    June 2017
29. SHENOLIKAR S
    A SMAP in the face for cancer.
    J Clin Invest. 2017;127:2048-2050.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: